Novo Nordisk’s Pill Pivot Faces Its First Big Test on Wednesday
Novo Nordisk’s shift to oral GLP-1 drugs faces pricing pressure and Eli Lilly competition as Q1 earnings loom,…
Oral Ozempic Hits Pharmacies as Earnings Test Investor Patience
Novo Nordisk launches oral Ozempic in the US amid Q1 earnings decline, Eli Lilly competition, and patent pressures.…
Generics, Q1 Results, and a Pipeline Showcase
Novo Nordisk enters a critical period with Q1 earnings, a Canadian Ozempic generic launch, and obesity conference data,…
Novo Nordisk’s Strategic Pivot Faces Crucial First-Quarter Test
Novo Nordisk shares down 20% YTD as it faces new oral obesity drug competition from Eli Lilly and…
Valneva’s Amsterdam Test: Investor Confidence on Trial
Valneva meets investors after Lyme vaccine trial miss and Chikungunya withdrawal trigger lawsuits and a 42% stock plunge.…
Valneva’s Amsterdam Test: Investor Confidence on Trial
Valneva meets investors after Lyme vaccine trial miss and Chikungunya withdrawal trigger lawsuits and a 42% stock plunge.…
A Litmus Test for Margins Amid Price Cuts
Novo Nordisk’s Q1 earnings will test profitability after global price cuts. EMA eases Wegovy storage rules, while generic…
OnePlus 15T bets on G2 esports chip for stable gaming performance
ⓘ OnePlus The OnePlus 15T is said to sport a 360° surround high-performance antenna setup. Pictured: the phone…
Ajax Vs Sparta Rotterdam: Stakes, Form Crises and a Managerial Test (3 Things to Watch)
Saturday’s fixture between Ajax and Sparta Rotterdam arrives as a crossroads for both clubs. The preview focuses on…
PS5 exclusive games on Switch 2 look less likely after LEGO Horizon Adventures leak
Microsoft has embraced Nintendo’s console, with Bethesda’s Fallout 4 as the latest example. However, there has been more…